Itonis Announces Hensley Brothers Distribution to Feature Emesyl™ Nausea Relief at the NACDS Total Store Expo

Posted 09:00:00 02/05/2015 by Admin


LAGUNA HILLS, Calif., Feb. 5, 2015 /PRNewswire/ -- Itonis, Inc. (OTC PINKSHEETS: ITNS) announced today that the distributor of EMESYL™ Nausea Relief, Hensley Brothers Distribution, LLC, will be featuring the product at the National Association of Chain Drug Stores (NACDS) Total Store Expo. The Expo, which is held during August 22-25, 2015 in Denver, Colorado, is the largest and most powerful convergence of drug, food, mass, and value retailing. The Expo has allowed suppliers to maximize selling opportunities to retailers by connecting with the buyers from more than 230 retail companies representing over 145,000 retail outlets.

"We are pleased that our distributor has made EMESYL™ Nausea Relief one of their priority products," said Mark Cheung, CEO of Itonis.

"While we will be presenting several of our products at the Expo, we plan to highlight EMESYL™ Nausea Relief. Things are moving fast with this product and we are ready to take this product to the next level," said Steven Hensley, Vice President of Hensley Brothers Distribution. "One reason we love this particular meeting is the unique guarantee of appointments with key retail buyers through a series of 10-minute pre-set meetings on the day prior to the opening of the exhibit hall. While we are beginning our big box retail plans now, this meeting presents a perfect opportunity to complete our mass retail objectives of getting EMESYL™ Nausea Relief in all the big box retailer pharmacies and grocery stores by the end of 2015."

About Emesyl™
www.itonisholdings.com/emesyl

About Itonis Pharmaceuticals

Itonis Pharmaceuticals, a division of Itonis, Inc., is headed by Charles Hensley, Ph.D., and its mission is to create and market over-the-counter and prescription homeopathic products that better people's lives. Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations. He was a founder of the company that launched the Zicam® Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States. Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.

About Itonis, Inc.

Located in Laguna Hills, California, and founded in 2005, Itonis Inc. has focused on transitioning itself in the past year from acquiring high growth, market niche entrepreneurial companies, to a market leader focused on the distribution of innovative products to the medical and pharmaceutical industry. Please visit www.itonisholdings.com.

Safe Harbor:

Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.



SOURCE ITONIS, INC.

http://www.prnewswire.com/news-releases/itonis-announces-hensley-brothers-distribution-to-feature-emesyl-nausea-relief-at-the-nacds-total-store-expo-300031415.html



 

Stock Quote - ITNS

ITNS Last:  $0.0012 Change:  --

Investor Relations

Itonis Holdings Company is a trade name of Itonis Inc. (OTC:ITNS), a publicly traded company.



Contact our office at (949) 200-8887 or email us at office@itonisholdings.com for more information.